Annual Accounts Receivable
$0.00
-$96.00 K-100.00%
31 December 2023
Summary:
Cyclerion Therapeutics annual accounts receivable is currently $0.00, with the most recent change of -$96.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$127.00 thousand (-100.00%). CYCN annual accounts receivable is now -100.00% below its all-time high of $1.47 million, reached on 31 December 2019.CYCN Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Receivable
$44.00 K
0.00%
30 September 2024
Summary:
Cyclerion Therapeutics quarterly accounts receivable is currently $44.00 thousandOver the past year, it has increased by +$44.00 thousand (+100.00%). CYCN quarterly accounts receivable is now -97.63% below its all-time high of $1.86 million, reached on 30 June 2019.CYCN Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CYCN Accounts Receivable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -100.0% | +100.0% |
| 3 y3 years | -100.0% | -72.2% |
| 5 y5 years | 0.0% | -96.9% |
CYCN Accounts Receivable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | -80.6% | ||
| 5 y | 5 years | -100.0% | -97.0% | ||
| alltime | all time | -100.0% | -97.6% |
Cyclerion Therapeutics Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $44.00 K(>+9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) |
| Sept 2023 | - | $0.00(0.0%) |
| June 2023 | - | $0.00(-100.0%) |
| Mar 2023 | - | $96.00 K(0.0%) |
| Dec 2022 | $96.00 K(-4.0%) | $96.00 K(-57.7%) |
| Sept 2022 | - | $227.00 K(0.0%) |
| June 2022 | - | $227.00 K(0.0%) |
| Mar 2022 | - | $227.00 K(+127.0%) |
| Dec 2021 | $100.00 K | $100.00 K(-36.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $158.00 K(>+9900.0%) |
| June 2021 | - | $0.00(0.0%) |
| Mar 2021 | - | $0.00(-100.0%) |
| Dec 2020 | $127.00 K(-91.4%) | $127.00 K(-68.3%) |
| Sept 2020 | - | $400.00 K(-46.7%) |
| June 2020 | - | $751.00 K(-26.8%) |
| Mar 2020 | - | $1.03 M(-30.4%) |
| Dec 2019 | $1.47 M(>+9900.0%) | $1.47 M(+2.4%) |
| Sept 2019 | - | $1.44 M(-22.5%) |
| June 2019 | - | $1.86 M(>+9900.0%) |
| Dec 2018 | $0.00 | $0.00 |
FAQ
- What is Cyclerion Therapeutics annual accounts receivable?
- What is the all time high annual accounts receivable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics annual accounts receivable year-on-year change?
- What is Cyclerion Therapeutics quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Cyclerion Therapeutics?
- What is Cyclerion Therapeutics quarterly accounts receivable year-on-year change?
What is Cyclerion Therapeutics annual accounts receivable?
The current annual accounts receivable of CYCN is $0.00
What is the all time high annual accounts receivable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high annual accounts receivable is $1.47 M
What is Cyclerion Therapeutics annual accounts receivable year-on-year change?
Over the past year, CYCN annual accounts receivable has changed by -$96.00 K (-100.00%)
What is Cyclerion Therapeutics quarterly accounts receivable?
The current quarterly accounts receivable of CYCN is $44.00 K
What is the all time high quarterly accounts receivable for Cyclerion Therapeutics?
Cyclerion Therapeutics all-time high quarterly accounts receivable is $1.86 M
What is Cyclerion Therapeutics quarterly accounts receivable year-on-year change?
Over the past year, CYCN quarterly accounts receivable has changed by +$44.00 K (+100.00%)